Skip to main content
. 2021 Jul 16;18:116. doi: 10.1186/s12984-021-00905-4

Table 5.

Changes in Clinical and PKG measures following treatment for bradykinesia or dyskinesia

a PwP treated for bradykinesia bradykinesia score ≥ 23 N = 57
Mean (Std) Δ% ES p value
 Hohn &Yahr 2.4 (1) n/a n/a n/a
 Years of PD 5.7 (3.8) n/a n/a
 PDQ39 Before 29.8 (19.4)
After 25.6 (19.1) 14.1% 0.22 0.26
 UPDRS III Before 38 (10.2)
After 32.7 (10.9) 13.9% 0.49 0.008
 UPDRS Total Before 65.8 (18.4)
After 55.7 (20.5) 15.4% 0.49 0.003
 Median BKS Before 29.4 (4.2)
After 27 (4.3) 8.2% 0.59 0.002
 PTB Before 63 (22)
After 50 (24) 20.6% 0.56 0.004
b PwP treated for dyskinesia PTD ≥ 20% N = 27
Mean (Std) Δ% ES p value
 Hohn &Yahr 2.4 (0.7) n/a n/a n/a
 Years of PD 9.4 (5.8) n/a n/a n/a
 UPDRS IV Before 7.7 (4)
After 4.3 (4.3) 44.2% 0.79 0.0009
 UPDRS Total Before 58 (18)
After 45 (23) 22.4% 0.57 0.010
 PTD Before 42 (20)
After 23 (16) 45.2% 1.19 0.0007
 Median DKS Before 14 (13)
After 6.2 (4.3) 54.9% 1.81 0.0006